Progression of fibrosis in chronic hepatitis C

Slides:



Advertisements
Similar presentations
Evaluation of Liver Histology in Clinical Trials for Chronic Viral Hepatitis Zachary Goodman, M.D., Ph.D. Chief, Hepatic Pathology Armed Forces Institute.
Advertisements

Hepatitis C virus-like particles synthesized in insect cells as a potential vaccine candidate Thomas F. Baumert, John Vergalla, Jujin Satoi, Michael Thomson,
Celiac disease–like abnormalities in a subgroup of patients with irritable bowel syndrome Ulrich Wahnschaffe, R. Ullrich, E.O. Riecken, J.D. Schulzke Gastroenterology.
Volume 46, Issue 3, Pages (March 2007)
Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection  Yi–Cheng Chen, I.–Shyan Sheen,
Incorrect Calculation and Inappropriate Interpretation: Accuracy of International Guidelines for Identifying Significant Fibrosis in e Antigen–Negative.
Acute hepatitis induced by greater celandine (Chelidonium majus)
Kester Crosse, Onuora G. Umeadi, Frank A
Anti–tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behçet's disease: A case report  Philip V. Hassard, Scott W. Binder, Viera.
Volume 131, Issue 2, Pages (August 2006)
Diagnosis of irritable bowel syndrome
Leptin, obesity, and liver disease
Lawrence K. Gates, Dawn V. Holladay  Gastroenterology 
Reactivation of Hepatitis B With Reappearance of Hepatitis B Surface Antigen After Chemotherapy and Immunosuppression  Tara N. Palmore, Neeral L. Shah,
Volume 144, Issue 5, Pages (May 2013)
Serologic Markers Do Not Predict Histologic Severity or Response to Treatment in Patients With Autoimmune Hepatitis  Vaibhav Mehendiratta, Pradnya Mitroo,
Volume 136, Issue 1, Pages (January 2009)
Suna Yapali, Nizar Talaat, Anna S. Lok 
Psychiatric disorders among veterans with hepatitis C infection
Volume 117, Issue 4, Pages (October 1999)
Volume 119, Issue 1, Pages (July 2000)
Volume 44, Pages S19-S24 (January 2006)
Changes in Serum Adipokine Levels During Pioglitazone Treatment for Nonalcoholic Steatohepatitis: Relationship to Histological Improvement  Glen Lutchman,
Peter R. Mueller-Abt, Kieran J. Frawley, Ristan M. Greer, Peter J
Volume 128, Issue 7, Pages (June 2005)
Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients  David Schoemaker, Robert Black, Lynne.
Appendectomy is followed by increased risk of Crohn's disease
Volume 123, Issue 4, Pages (October 2002)
Gastroenterology news
Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C  Chi–Jen Chu, Munira Hussain,
Volume 120, Issue 3, Pages (February 2001)
Volume 137, Issue 2, Pages (August 2009)
Volume 122, Issue 3, Pages (March 2002)
Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis  William R Kessler, Oscar W Cummings, George Eckert, Naga Chalasani,
From non-A, non-B hepatitis to hepatitis C virus cure
Volume 141, Issue 5, Pages e9 (November 2011)
Volume 42, Issue 2, Pages (February 2005)
A. James Hanje, Lindsay J. Pell, Nicholas A. Votolato, Wendy L
Volume 114, Issue 1, Pages (January 1998)
Volume 120, Issue 4, Pages (March 2001)
Severe Constipation Clinical Gastroenterology and Hepatology
Volume 119, Issue 4, Pages (October 2000)
Importance of Specimen Size in Accurate Needle Liver Biopsy Evaluation of Patients With Chronic Hepatitis C  Thomas D. Schiano, Samia Azeem, Carol A.
Clinical and Histologic Features of Azithromycin-Induced Liver Injury
Severe Hepatic Side Effects of Ezetimibe
AGA technical review on nonalcoholic fatty liver disease
AGA technical review on celiac sprue
Sharon J. Hutchinson, Sheila M. Bird, David J. Goldberg 
Psychiatric disorders among veterans with hepatitis C infection
Volume 50, Issue 3, Pages (March 2009)
Image of the month Gastroenterology
Volume 121, Issue 5, Pages (November 2001)
Alan Bonder, MD, Nezam H. Afdhal, MD 
Suna Yapali, MD, Anna S. Lok, MD, FRCP 
Volume 135, Issue 6, Pages e2 (December 2008)
Histological outcome during long-term lamivudine therapy
Chronic Diarrhea Clinical Gastroenterology and Hepatology
Volume 121, Issue 2, Pages (August 2001)
AGA technical review on osteoporosis in gastrointestinal diseases
Volume 122, Issue 4, Pages (April 2002)
Chronic Hepatitis C in Patients With Persistently Normal Alanine Transaminase Levels  Mitchell L. Shiffman, Moisés Diago, Albert Tran, Paul Pockros, Robert.
Clinical Gastroenterology and Hepatology
Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection  Yi–Cheng Chen, I.–Shyan Sheen,
Raymond D’Souza, Michael J
Hepatic deficiency of interleukin 10 in chronic hepatitis C
Volume 134, Issue 7, Pages (June 2008)
Hepatic oxygen supplementation as therapy in cirrhotic liver disease
Fulminant Hepatic Failure Secondary to Erlotinib
Volume 120, Issue 4, Pages (March 2001)
Volume 1, Issue 1, Pages (May 2019)
Presentation transcript:

Progression of fibrosis in chronic hepatitis C Marc G. Ghany, David E. Kleiner, Harvey Alter, Edward Doo, Farooq Khokar, Kittichai Promrat, David Herion, Yoon Park, T.Jake Liang, Jay H. Hoofnagle  Gastroenterology  Volume 124, Issue 1, Pages 97-104 (January 2003) DOI: 10.1053/gast.2003.50018 Copyright © 2003 American Gastroenterological Association Terms and Conditions

Fig. 1 Mean rate of worsening scores for fibrosis per year between 2 liver biopsies according to (A) patient age at initial liver biopsy (by every 15 years), (B) initial ALT level (n = 118; by fold elevation above the upper limit of normal), and (C) initial reading for periportal necrosis and inflammation (0–1, no or mild piecemeal necrosis; 3–4, moderate or marked piecemeal necrosis; 5–6, moderate or marked piecemeal necrosis plus bridging necrosis; 10, multilobular necrosis). The Knodell scores for lobular and portal inflammation are not included in this figure; hence, the maximal score is 10 and not 18. Gastroenterology 2003 124, 97-104DOI: (10.1053/gast.2003.50018) Copyright © 2003 American Gastroenterological Association Terms and Conditions